Group 1 - The 2026 Offshore Technology Conference (OTC) will take place from May 4 to May 7, 2026, at the NRG Center in Houston, Texas, organized by the American Petroleum Institute [1] - The exhibition area will cover 50,000 square meters, with an expected attendance of 66,412 visitors and participation from 2,350 exhibitors [1] - OTC is recognized as a major global event in the oil and gas industry, showcasing the latest technologies, products, and services related to exploration, extraction, production, processing, storage, and transportation [1][2] Group 2 - OTC serves as a platform for showcasing the latest products and technologies, facilitating industry information exchange, and promoting business collaboration and new commercial opportunities [2] - The conference will include a series of seminars, forums, and summits aimed at providing learning and networking opportunities for exhibitors and attendees [2] - The goal of OTC is to foster the development and innovation of the global oil and gas industry, enhancing technologies and services while promoting sustainable growth [2] Group 3 - The exhibition will feature various product categories, including mechanical equipment such as drilling rigs, welding equipment, and pumps, as well as safety products and industrial equipment [3][4] - Specific areas of focus will include environmental equipment, non-metallic devices, valves, pipelines, and instrumentation related to oil and gas operations [3][4] - The refining and petrochemical section will cover technologies and equipment for oil refining processes, petrochemical processes, and advanced materials [4]

Core Viewpoint - Huhua Co., Ltd. (003002) has established itself as a quality enterprise in the civil explosive materials industry, demonstrating a comprehensive capability in research, production, sales, import and export, and integrated blasting engineering services [1] Group 1 - The company is one of the early adopters of the "production-sales-explosion" integrated development model in the industry [1] - The subsidiary, Shanxi Huhua Group Blasting Co., Ltd., holds dual first-class qualifications for engineering blasting and mining construction general contracting [1] Group 2 - The company has proposed a "Westward Strategy" to actively pursue relevant projects in regions such as Tibet and Xinjiang [1]

Group 1 - The company, 泰德医药 (Tide Pharmaceutical), plans to globally offer 16.8 million H-shares, with 1.68 million shares available in Hong Kong and 15.12 million shares for international offering [1] - The subscription period for the shares is set from June 20 to June 25, 2025, with the expected pricing date on June 26, 2025, and trading on the Hong Kong Stock Exchange anticipated to start on June 30, 2025 [1] - The proposed price range for the shares is between HKD 28.40 and HKD 30.60, with a trading unit of 100 shares [1] Group 2 - According to Frost & Sullivan, the company is the third largest global player in the peptide-focused CRDMO market, holding a market share of 1.5% as of 2023 [2] - The company provides a full cycle of services from early discovery, preclinical research, clinical development to commercial production, primarily focusing on API rather than finished drugs [2] - The company has established stable customer relationships in over 50 countries, including major markets such as China, the USA, Japan, Europe, South Korea, and Australia [2] Group 3 - The company has signed cornerstone investment agreements, with cornerstone investors agreeing to subscribe for a total of 2.6608 million shares at a hypothetical price of HKD 29.50, amounting to approximately USD 10 million (around HKD 78.49 million) [3] - The estimated net proceeds from the global offering are approximately HKD 411.2 million, assuming a share price of HKD 29.50 [3] - The intended use of the net proceeds includes approximately 76.4% for expanding service capacity and production facilities in the USA and China, 4.1% for expanding capacity in China, 9.5% for establishing sales and after-sales service networks in more regions, and 10.0% for working capital and other general corporate purposes [3]